Myoinositol Improves Embryo Development in PCOS Patients Undergoing ICSI

الملخص EN

The aim of this study was to investigate the activity of myoinositol, in a court of 217 PCOS women undergoing intracytoplasmic sperm injection (ICSI), on pregnancy rate, embryo development, estradiol, and progesterone concentration in blood serum, superoxide dismutase (SOD), and catalase (CAT) in follicular fluid.

Concerning the court of patient, 112 (groups I and II) out of 217 were PCOS women, whereas group III consisted of healthy subjects (not PCOS).

Group I patients were treated with 400 μg of folic acid per day for 3 months before ICSI, whereas group II patients received 4000 mg of myoinositol and 400 μg of folic acid per day for 3 months before ICSI.

Group II revealed a shorter embryo/blastocyst development period between microinjection and 5-cell stage compared to group I.

The difference in SOD concentration between groups I and II and between groups II and III was statistically significant.

In group II, 34.62% of pregnancies were obtained, whereas in group I this number reached 20% (NS).

Myoinositol increased embryo development dynamics and accelerated blastocyst stage reaching time; however, no effect was shown on clinical pregnancy.

Furthermore, it restored SOD concentration, lowered in PCOS women, but did not exert any effect on CAT concentration.